Products that promote the incidence of cancer. WHO Base. Sorting in order from highest to lowest effect.
Agents Classified by the IARC Monographs, Volumes 1—122 | |||||
CAS No. | Agent | Group | Volume | Year | Additional information |
High-temperature frying (see Frying) | |||||
Household combustion of biomass fuel (see Biomass fuel, indoor emissions from household combustion of) | |||||
Household combustion of coal (see Coal, indoor emissions from household combustion) | |||||
Human herpesvirus type 4 (see Epstein-Barr virus) | |||||
Human herpesvirus type 8 (see Kaposi sarcoma herpesvirus) | |||||
Human immunodeficiency virus type 1 (infection with) | 1 | 67, 100B | 2012 | ||
Human immunodeficiency virus type 2 (infection with) | 2B | 67 | 1996 | ||
Human papillomavirus genus beta (except types 5 and 8) and genus gamma | 3 | 90, 100B | 2012 | ||
Human papillomavirus type 68 | 2A | 100B | 2012 | ||
Human papillomavirus types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59 | 1 | 64, 90, 100B | 2012 | NB: The HPV types that have been classified as carcinogenic to humans can differ by an order of magnitude in risk for cervical cancer | |
Human papillomavirus types 26, 53, 66, 67, 70, 73, 82 | 2B | 100B | 2012 | ||
Human papillomavirus types 30, 34, 69, 85, 97 | 2B | 100B | 2012 | NB: Classified by phylogenetic analogy to the HPV genus alpha types classified in Group 1 | |
Human papillomavirus types 5 and 8 (in patients with epidermodysplasia verruciformis) | 2B | 100B | 2012 | ||
Human papillomavirus types 6 and 11 | 3 | 90, 100B | 2012 | ||
Human T-cell lymphotropic virus type I | 1 | 67, 100B | 2012 | ||
Human T-cell lymphotropic virus type II | 3 | 67 | 1996 | ||
Hypochlorite salts | 3 | 52 | 1991 | ||
Implanted foreign bodies of metallic chromium or titanium and of cobalt-based, chromium-based, and titanium-based alloys, stainless steel and depleted uranium | 3 | 74 | 1999 | ||
Implanted foreign bodies of metallic cobalt, metallic nickel and an alloy powder containing 66-67% nickel, 13-16% chromium, and 7% iron | 2B | 74 | 1999 | ||
Insulation glass wool | 3 | 43, 81 | 2002 | ||
Involuntary smoking (see Tobacco smoke, second-hand) | |||||
Ionizing radiation (all types) | 1 | 100D | 2012 | ||
Iron and steel founding (occupational exposure during) | 1 | 34, Sup 7, 100F | 2012 | ||
Isopropyl alcohol manufacture using strong acids | 1 | Sup 7, 100F | 2012 | ||
Isopropyl oils | 3 | 15, Sup 7, 71 | 1999 | ||
JC polyomavirus (JCV) | 2B | 104 | 2014 | ||
Jet fuel | 3 | 45 | 1989 | ||
Kaposi sarcoma herpesvirus | 1 | 70, 100B | 2012 | ||
Lead compounds, inorganic | 2A | Sup 7, 87 | 2006 | ||
Lead compounds, organic | 3 | 23, Sup 7, 87 | 2006 | NB: Organic lead compounds are metabolized at least in part, to ionic lead both in humans and animals. To the extent that ionic lead, generated from organic lead, is present in the body, it will be expected to exert the toxicities associated with inorganic lead | |
Leather dust | 1 | 100C | 2012 | ||
Leather goods manufacture | 3 | 25, Sup 7 | 1987 | ||
Leather tanning and processing | 3 | 25, Sup 7 | 1987 | ||
Lumber and sawmill industries (including logging) | 3 | 25, Sup 7 | 1987 | ||
Madder root (Rubia tinctorum) | 3 | 82 | 2002 | ||
Magenta production | 1 | Sup 7, 57, 99, 100F | 2012 | ||
Magnetic fields, extremely low-frequency | 2B | 80 | 2002 | ||
Magnetic fields, static | 3 | 80 | 2002 | ||
Malaria (caused by infection with Plasmodium falciparum in holoendemic areas) | 2A | 104 | 2014 | ||
Mate, not very hot (drinking) | 3 | 51, 116 | 2018 online | ||
Mate, hot (see Very hot beverages) | |||||
Merkel cell polyomavirus (MCV) | 2A | 104 | 2014 | ||
Metabisulfites | 3 | 54 | 1992 | ||
Metallic implants prepared as thin smooth films | 2B | 74 | 1999 | ||
Methylmercury compounds | 2B | 58 | 1993 | NB: Evaluated as a group | |
Microcystis extracts | 3 | 94 | 2010 | ||
Mineral oils, highly-refined | 3 | 33, Sup 7 | 1987 | ||
Mineral oils, untreated or mildly treated | 1 | 33, Sup 7, 100F | 2012 | ||
Modacrylic fibres | 3 | 19, Sup 7 | 1987 | ||
MOPP and other combined chemotherapy including alkylating agents | 1 | Sup 7, 100A | 2012 | ||
Neutron radiation | 1 | 75, 100D | 2012 | NB: Overall evaluation upgraded to Group 1 with supporting evidence from other relevant data | |
Nickel compounds | 1 | Sup 7, 49, 100C | 2012 | ||
Nickel refining (see Nickel compounds) | 11 | 1976 | |||
Nitrate or nitrite (ingested) under conditions that result in endogenous nitrosation | 2A | 94 | 2010 | ||
Non-arsenical insecticides (occupational exposures in spraying and application of) | 2A | 53 | 1991 | ||
Oestrogen (see Estrogen) | |||||
Opisthorchis felineus (infection with) | 3 | 61 | 1994 | ||
Opisthorchis viverrini (infection with) | 1 | 61, 100B | 2012 | ||
Oral contraceptives, combined estrogen-progestogen (see Estrogen-progestogen oral contraceptives) | |||||
Organic polymeric materials | 3 | 74 | 1999 | ||
Orthopaedic implants of complex composition and cardiac pacemakers | 3 | 74 | 1999 | ||
List_of_Classifications.pdf